The live webcast for the Evercore fireside chat will be accessible through the “Events” section of the Investor Relations tab ...
It is unclear what will happen to ProKidney's plans for a $458-million, 330-job commercial manufacturing facility in ...
The buildings are being purchased "to support the company’s manufacturing operations for rilparencel, the company’s lead ...
Headquartered in Winston-Salem, ProKidney leases an undetermined amount of space at the general-industrial-zoned building at ...
The fate is uncertain for a proposed high-profile ProKidney Corp. manufacturing plant in Greensboro after the Winston-Salem ...
ProKidney WINSTON-SALEM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the development of a first-in ...
ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney's lead product candidate, rilparencel ...
The live webcast for the Evercore fireside chat will be accessible through the“Events” section of the Investor Relations tab within ProKidney's website at . Investors interested in one-on-one ...
WFMY News2 on MSN9d
ProKidney no longer coming to Greensboro, Chamber of Commerce confirmsGREENSBORO, N.C. — Biotech company ProKidney will no longer be coming to Greensboro, according to the City of Greensboro ...
ProKidney, which works to treat chronic kidney disease, had previously announced plans to expand its operation into ...
As the U.S. stock market continues its rally, with the Dow Jones Industrial Average reaching record highs and the S&P 500 extending its winning streak, investors are increasingly exploring diverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback